AURA / Aura Biosciences, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Aura Biosciences, Inc.
US ˙ NasdaqGM ˙ US05153U1079

Deler fremragende 64,199,778 shares
Insideraktier9.257.905 shares
Insider ejerskab14,42 %
Total Insiders21
Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

-5 ( )
10645 out of 10986

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

-0.313% ( )
10542 out of 10856

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

Aura Biosciences, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Teresa Marie Bitetti Director - [D] 21.000 21.000
Rosch Mark De Chief Operating Officer - [O] 58.635 58.635
Amy Elazzouzi Senior Vice President, Finance - [O] 120.060 120.060
Julie B Feder Chief Financial Officer - [O] 134.276 134.276
Goel David E. 10% Owner - [10%] 4.112.870 6.922.870
Anthony S Gibney See Remarks - [O] 278.178 278.178
Janet Jill Hopkins Chief Medical Officer - [O] 321.340 321.340
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
David Michael Johnson Director - [D] 179.167 179.167
Conor Kilroy See Remarks - [O] 217.835 217.835
Matrix Capital Management Company, LP 10% Owner - [10%] 6.922.870 6.922.870
Mattessich Antony C. Director - [D] 23.500 23.500
Medicxi Growth Co-Invest I LP 10% Owner - [10%] 70.540 70.540
Medicxi Growth I GP Ltd 10% Owner - [10%] 70.540 70.540
Medicxi Growth I LP 10% Owner - [10%] 70.540 70.540
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Ventures Management (Jersey) Ltd Medicxi 10% Owner - [10%] 70.540 70.540
Rajesh B Parekh 16.000
Mark Plavsic Chief Technology Officer - [O] 243.736 243.736
Christopher Brett Primiano Chief Business Officer - [O] 8.750 8.750
Cadmus Rich See Remarks - [O] 58.703 58.703
Sapna Srivastava Director - [D] 23.500 23.500
los Pinos Elisabet de See Remarks, Director - [D] [O] 575.815 575.815

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i AURA / Aura Biosciences, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2025-05-16 Gibney Anthony S 50.000 4,9000 50.000 4,9000 245.000 341 7.4900 129.500 52,86
2025-05-16 Johnson David Michael 20.000 4,9000 20.000 4,9000 98.000
2023-11-09 Matrix Capital Management Company, LP 1.560.000 9,0000 1.560.000 9,0000 14.040.000
2023-11-08 Johnson David Michael 9.601 7,3000 9.601 7,3000 70.087
2023-11-08 Johnson David Michael 10.000 7,3000 10.000 7,3000 73.000
2023-11-08 Johnson David Michael 10.000 7,3000 10.000 7,3000 73.000
2023-11-07 Johnson David Michael 47.000 7,1700 47.000 7,1700 336.990
2023-11-07 Johnson David Michael 76.000 7,1700 76.000 7,1700 544.920
2023-11-07 Johnson David Michael 47.000 7,1700 47.000 7,1700 336.990

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

AURA / Aura Biosciences, Inc. Insider Trades
Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i AURA / Aura Biosciences, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2026-04-16 Kilroy Conor 11.738 7,0200 11.738 7,0200 82.401 13 6.7300 -3.403 -4,13
2026-02-17 de los Pinos Elisabet 47.648 5,0600 47.648 5,0600 241.099
2026-02-17 Elazzouzi Amy 8.549 5,0600 8.549 5,0600 43.258
2026-02-17 Plavsic Mark 15.890 5,0500 15.890 5,0500 80.244
2026-02-17 Hopkins Janet Jill 20.401 5,0600 20.401 5,0600 103.229
2026-02-17 Kilroy Conor 12.079 5,0500 12.079 5,0500 60.999
2026-01-20 de los Pinos Elisabet 16.928 4,8600 16.928 4,8600 82.270
2026-01-20 Elazzouzi Amy 1.581 4,8600 1.581 4,8600 7.684
2025-11-17 Hopkins Janet Jill 17.109 5,4200 17.109 5,4200 92.731

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

AURA / Aura Biosciences, Inc. Insider Trades
Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil
Dato
Handle
Dato
Form Insider Ticker Sikkerhedstitel Kode 10b5-1 Direkte Dyrke motion
Pris
Enhed
Pris
Enheder
Ændret
Værdi
Ændret (1K)
Tilbage
Muligheder
Tilbage
Aktier
2026-04-16 2026-04-16 4 Kilroy Conor AURA Common Stock S - Sale D 7,0200 -11.738 -82 217.835
2026-03-03 2026-03-02 4 de los Pinos Elisabet AURA Common Stock A - Award D 166.000 575.815
2026-03-03 2026-03-02 4 Gibney Anthony S AURA Common Stock A - Award D 71.245 278.178
2026-03-03 2026-03-02 4 Kilroy Conor AURA Common Stock A - Award D 62.339 229.573
2026-03-03 2026-03-02 4 Hopkins Janet Jill AURA Common Stock A - Award D 89.056 321.340
2026-03-03 2026-03-02 4 Plavsic Mark AURA Common Stock A - Award D 62.339 243.736
2026-03-03 2026-03-02 4 Elazzouzi Amy AURA Common Stock A - Award D 44.528 120.060
2026-02-17 2026-02-17 4 Plavsic Mark AURA Common Stock S - Sale D 5,0500 -15.890 -80 181.397
2026-02-17 2026-02-17 4 Kilroy Conor AURA Common Stock S - Sale D 5,0500 -12.079 -61 167.234
2026-02-17 2026-02-17 4 Elazzouzi Amy AURA Common Stock S - Sale D 5,0600 -8.549 -43 75.532
2026-02-17 2026-02-17 4 Hopkins Janet Jill AURA Common Stock S - Sale D 5,0600 -20.401 -103 232.284
2026-02-17 2026-02-17 4 de los Pinos Elisabet AURA Common Stock S - Sale D 5,0600 -47.648 -241 409.815
2026-01-20 2026-01-20 4 Elazzouzi Amy AURA Common Stock S - Sale D 4,8600 -1.581 -8 84.081
2026-01-20 2026-01-20 4 de los Pinos Elisabet AURA Common Stock S - Sale D 4,8600 -16.928 -82 457.463
2025-11-17 2025-11-17 4 Hopkins Janet Jill AURA Common Stock S - Sale D 5,4200 -17.109 -93 252.685
2025-10-29 2025-10-29 4 de los Pinos Elisabet AURA Common Stock S - Sale D 6,3500 -9.049 -57 474.391
2025-10-29 2025-10-29 4 Elazzouzi Amy AURA Common Stock S - Sale D 6,3500 -896 -6 85.662
2025-10-16 2025-10-16 4 Plavsic Mark AURA Common Stock S - Sale D 6,3500 -12.169 -77 197.287
2025-08-18 2025-08-18 4 Elazzouzi Amy AURA Common Stock S - Sale D 6,7000 -7.722 -52 86.558
2025-08-18 2025-08-18 4 Elazzouzi Amy AURA Common Stock M - Exercise D 4,2500 2.319 10 94.280
2025-08-18 2025-08-18 4 Elazzouzi Amy AURA Common Stock M - Exercise D 3,1600 1.094 3 91.961
2025-08-18 2025-08-18 4 Elazzouzi Amy AURA Common Stock M - Exercise D 2,7400 4.744 13 90.867
2025-08-18 2025-08-18 4 Elazzouzi Amy AURA Common Stock M - Exercise D 5,2100 547 3 86.123
2025-08-18 2025-08-18 4 Elazzouzi Amy AURA Common Stock M - Exercise D 5,4800 547 3 85.576
2025-08-18 2025-08-18 4 Elazzouzi Amy AURA Common Stock M - Exercise D 5,4800 1.094 6 85.029
2025-08-18 2025-08-18 4 Elazzouzi Amy AURA Common Stock M - Exercise D 5,0700 2.554 13 83.935
2025-06-18 2025-06-17 4 Johnson David Michael AURA Common Stock A - Award D 13.000 179.167
2025-06-18 2025-06-17 4 Srivastava Sapna AURA Common Stock A - Award D 13.000 23.500
2025-06-18 2025-06-17 4 Mattessich Antony C. AURA Common Stock A - Award D 13.000 23.500
2025-06-04 2025-06-02 4 de los Pinos Elisabet AURA Common Stock F - Taxes D 6,1600 -9.948 -61 483.440
2025-06-04 2025-06-02 4 de los Pinos Elisabet AURA Common Stock M - Exercise D 5,0700 10.948 56 493.388
2025-06-04 2025-06-02 4 Gibney Anthony S AURA Common Stock A - Award D 150.000 206.933
2025-05-20 2025-05-16 4 Gibney Anthony S AURA Common Stock S - Sale D 5,1500 -1.519 -8 56.933
2025-05-20 2025-05-16 4 Gibney Anthony S AURA Common Stock P - Purchase D 4,9000 50.000 245 58.452
2025-05-20 2025-05-16 4 Johnson David Michael AURA Common Stock P - Purchase D 4,9000 20.000 98 166.167
2025-05-16 3 Gibney Anthony S AURA Common Stock D 8.452
2025-04-16 2025-04-16 4 Elazzouzi Amy AURA Common Stock S - Sale D 5,4900 -897 -5 81.381
2025-04-16 2025-04-16 4 Kilroy Conor AURA Common Stock S - Sale D 5,4900 -7.162 -39 179.313
2025-04-02 2025-03-31 4 Bitetti Teresa Marie AURA Common Stock A - Award D 21.000 21.000
2025-02-18 2025-02-18 4 Plavsic Mark AURA Common Stock S - Sale D 7,7500 -2.151 -17 209.456
2025-02-18 2025-02-18 4 Elazzouzi Amy AURA Common Stock S - Sale D 7,7500 -1.404 -11 82.278
2025-02-18 2025-02-18 4 Hopkins Janet Jill AURA Common Stock S - Sale D 7,7500 -2.534 -20 269.794
2025-02-18 2025-02-18 4 de los Pinos Elisabet AURA Common Stock S - Sale D 7,7541 -20.221 -157 482.440
2025-02-04 2025-02-03 4 Plavsic Mark AURA Common Stock A - Award D 90.475 211.607
2025-02-04 2025-02-03 4 de los Pinos Elisabet AURA Common Stock A - Award D 194.320 502.661
2025-02-04 2025-02-03 4 Elazzouzi Amy AURA Common Stock A - Award D 45.240 83.682
2025-02-04 2025-02-03 4 Kilroy Conor AURA Common Stock A - Award D 90.475 186.475
2025-02-04 2025-02-03 4 Hopkins Janet Jill AURA Common Stock A - Award D 120.635 272.328
2025-01-21 2025-01-21 4 de los Pinos Elisabet AURA Common Stock S - Sale D 7,6704 -15.955 -122 304.692
2025-01-21 2025-01-21 4 Elazzouzi Amy AURA Common Stock S - Sale D 7,6715 -1.001 -8 38.442
2024-11-18 2024-11-18 4 Hopkins Janet Jill AURA Common Stock S - Sale D 9,3608 -11.822 -111 151.693
2024-10-29 2024-10-29 4 de los Pinos Elisabet AURA Common Stock S - Sale D 10,7378 -9.200 -99 320.647
2024-10-29 2024-10-29 4 Elazzouzi Amy AURA Common Stock S - Sale D 10,7385 -553 -6 39.443
2024-10-29 3 Elazzouzi Amy AURA Common Stock D 39.996
2024-10-21 2024-10-18 4 Feder Julie B AURA Common Stock S - Sale D 12,0314 -25.131 -302 134.276
2024-10-21 2024-10-18 4 Feder Julie B AURA Common Stock M - Exercise D 5,4800 5.000 27 159.407
2024-10-21 2024-10-18 4 Feder Julie B AURA Common Stock M - Exercise D 4,2500 2.631 11 154.407
2024-10-21 2024-10-18 4 Feder Julie B AURA Common Stock M - Exercise D 2,7400 17.500 48 151.776
2024-10-18 2024-10-18 4 de los Pinos Elisabet AURA Common Stock S - Sale D 12,0374 -24.992 -301 329.847
2024-10-18 2024-10-18 4 de los Pinos Elisabet AURA Common Stock M - Exercise D 2,7400 24.992 68 354.839
2024-10-16 2024-10-16 4 Plavsic Mark AURA Common Stock S - Sale D 9,8500 -7.383 -73 121.132
2024-10-01 2024-09-27 4 de los Pinos Elisabet AURA Common Stock M - Exercise D 5,7600 5.474 32 329.847
2024-06-24 2024-06-20 4 Mattessich Antony C. AURA Common Stock A - Award D 10.500 10.500
2024-06-24 2024-06-20 4 Srivastava Sapna AURA Common Stock A - Award D 10.500 10.500
2024-06-24 2024-06-20 4 Johnson David Michael AURA Common Stock A - Award D 10.500 146.167
2024-04-04 2024-04-02 4 Kilroy Conor AURA Common Stock A - Award D 96.000 96.000
2024-03-25 3 Plavsic Mark AURA Common Stock D 128.515
2024-02-02 2024-02-01 4 de los Pinos Elisabet AURA Common Stock A - Award D 162.935 324.373
2024-02-02 2024-02-01 4 Feder Julie B AURA Common Stock A - Award D 71.285 134.276
2024-02-02 2024-02-01 4 Hopkins Janet Jill AURA Common Stock A - Award D 28.515 163.515
2024-01-24 2024-01-23 4 Feder Julie B AURA Common Stock S - Sale D 7,6443 -6.609 -51 62.991
2024-01-24 2024-01-23 4 de los Pinos Elisabet AURA Common Stock S - Sale D 7,6415 -15.853 -121 161.438
2023-11-09 2023-11-09 4 Matrix Capital Management Company, LP See footnotes AURA Common Stock, par value $0.00001 per share (Common Stock) P - Purchase I 9,0000 1.560.000 14.040 6.922.870
2023-11-09 2023-11-08 4 Johnson David Michael By NEJ09 IRREVOCABLE TRUST AURA Common Stock P - Purchase I 7,3000 10.000 73 75.000
2023-11-09 2023-11-08 4 Johnson David Michael By NEJ12 IRREVOCABLE TRUST AURA Common Stock P - Purchase I 7,3000 10.000 73 75.000
2023-11-09 2023-11-08 4 Johnson David Michael AURA Common Stock P - Purchase D 7,3000 9.601 70 135.667
2023-11-09 2023-11-07 4 Johnson David Michael By NEJ09 IRREVOCABLE TRUST AURA Common Stock P - Purchase I 7,1700 47.000 337 65.000
2023-11-09 2023-11-07 4 Johnson David Michael By NEJ09 IRREVOCABLE TRUST AURA Common Stock P - Purchase I 7,1700 47.000 337 65.000
2023-11-09 2023-11-07 4 Johnson David Michael AURA Common Stock P - Purchase D 7,1700 76.000 545 126.066
2023-11-07 2023-11-06 4 Feder Julie B AURA Common Stock S - Sale D 12,0651 -3.900 -47 69.600
2023-11-07 2023-11-06 4 Feder Julie B AURA Common Stock M - Exercise D 2,7400 3.900 11 73.500
2023-11-07 2023-11-06 4 de los Pinos Elisabet AURA Common Stock S - Sale D 12,0299 -7.449 -90 177.291
2023-11-07 2023-11-06 4 de los Pinos Elisabet AURA Common Stock M - Exercise D 2,7400 3.800 10 184.740
2023-11-03 2023-11-01 4 Hopkins Janet Jill AURA Common Stock A - Award D 135.000 135.000
2023-11-01 2023-10-30 4 Feder Julie B AURA Common Stock S - Sale D 6,8215 -3.385 -23 69.600
2023-11-01 2023-10-30 4 de los Pinos Elisabet AURA Common Stock S - Sale D 6,8306 -9.586 -65 180.940
2023-10-05 2023-10-04 4 Johnson David Michael AURA Common Stock P - Purchase D 8,6068 6.566 57 50.066
2023-10-05 2023-10-03 4 Johnson David Michael AURA Common Stock P - Purchase D 8,2713 13.500 112 43.500
2023-01-23 2023-01-19 4 Rich Cadmus AURA Common Stock A - Award D 34.125 58.703
2023-01-23 2023-01-19 4 de los Pinos Elisabet AURA Common Stock A - Award D 121.875 190.526
2023-01-23 2023-01-19 4 Feder Julie B AURA Common Stock A - Award D 48.750 72.985
2023-01-23 2023-01-19 4 De Rosch Mark AURA Common Stock A - Award D 42.250 58.635
2023-01-09 2023-01-06 4 Johnson David Michael By NEJ12 IRREVOCABLE TRUST AURA Common Stock P - Purchase I 10,5100 904 10 18.000
2023-01-09 2023-01-06 4 Johnson David Michael By NEJ09 IRREVOCABLE TRUST AURA Common Stock P - Purchase I 10,5000 700 7 18.000
2023-01-09 2023-01-05 4 Johnson David Michael By NEJ12 IRREVOCABLE TRUST AURA Common Stock P - Purchase I 10,0000 96 1 17.096
2023-01-09 2023-01-05 4 Johnson David Michael By NEJ09 IRREVOCABLE TRUST AURA Common Stock P - Purchase I 10,0000 300 3 17.300
2022-12-30 2022-12-28 4 Johnson David Michael By NEJ12 IRREVOCABLE TRUST AURA Common Stock P - Purchase I 9,7500 2.000 20 17.000
2022-12-30 2022-12-28 4 Johnson David Michael By NEJ09 IRREVOCABLE TRUST AURA Common Stock P - Purchase I 9,7500 2.000 20 17.000
2022-12-15 2022-12-01 4 Johnson David Michael By NEJ09 IRREVOCABLE TRUST AURA Common Stock P - Purchase I 12,3700 5.000 62 15.000
2022-12-15 2022-12-01 4 Johnson David Michael By NEJ12 IRREVOCABLE TRUST AURA Common Stock P - Purchase I 12,3700 5.000 62 15.000
2022-12-07 2022-12-05 4 Matrix Capital Management Company, LP See footnotes AURA Common Stock, par value $0.00001 per share ("Common Stock") P - Purchase I 12,0000 1.250.000 15.000 5.362.870
2022-11-02 2022-10-31 4 Feder Julie B AURA Common Stock S - Sale D 12,4514 -2.015 -25 24.235
2022-11-02 2022-10-31 4 de los Pinos Elisabet AURA Common Stock S - Sale D 12,4574 -5.706 -71 68.651
2022-11-02 2022-10-31 4 Rich Cadmus AURA Common Stock S - Sale D 12,4481 -1.672 -21 24.578
2022-11-02 2022-10-31 4 De Rosch Mark AURA Common Stock S - Sale D 12,4574 -1.115 -14 16.385
2022-06-14 2022-06-13 4 Johnson David Michael AURA Common Stock P - Purchase D 13,9900 20.000 280 30.000
2022-06-14 2022-06-13 4 Johnson David Michael By NEJ12 IRREVOCABLE TRUST AURA Common Stock P - Purchase I 13,9900 7.000 98 10.000
2022-06-14 2022-06-13 4 Johnson David Michael By NEJ09 IRREVOCABLE TRUST AURA Common Stock P - Purchase I 13,9900 7.000 98 10.000
2022-06-14 2022-06-10 4 Johnson David Michael AURA Common Stock P - Purchase D 15,0400 10.000 150 10.000
2022-06-14 2022-06-10 4 Johnson David Michael By NEJ12 IRREVOCABLE TRUST AURA Common Stock P - Purchase I 15,0400 3.000 45 3.000
2022-06-14 2022-06-10 4 Johnson David Michael By NEJ09 IRREVOCABLE TRUST AURA Common Stock P - Purchase I 15,0400 3.000 45 3.000
2021-11-04 2021-11-02 4 Medicxi Ventures Management (Jersey) Ltd AURA Series E Convertible Preferred Stock C - Conversion I -5.975 0
2021-11-04 2021-11-02 4 Medicxi Ventures Management (Jersey) Ltd AURA Series D-2 Convertible Preferred Stock C - Conversion I -8.876 0
2021-11-04 2021-11-02 4 Medicxi Ventures Management (Jersey) Ltd AURA Series D-1 Convertible Preferred Stock C - Conversion I -39.214 0
2021-11-04 2021-11-02 4 Medicxi Ventures Management (Jersey) Ltd AURA Series E Convertible Preferred Stock C - Conversion I -251.545 0
2021-11-04 2021-11-02 4 Medicxi Ventures Management (Jersey) Ltd AURA Series D-2 Convertible Preferred Stock C - Conversion I -373.606 0
2021-11-04 2021-11-02 4 Medicxi Ventures Management (Jersey) Ltd AURA Series D-1 Convertible Preferred Stock C - Conversion I -1.650.676 0
2021-11-04 2021-11-02 4 Medicxi Ventures Management (Jersey) Ltd AURA Common Stock P - Purchase I 14,0000 16.475 231 70.540
2021-11-04 2021-11-02 4 Medicxi Ventures Management (Jersey) Ltd AURA Common Stock C - Conversion I 54.065 54.065
2021-11-04 2021-11-02 4 Medicxi Ventures Management (Jersey) Ltd AURA Common Stock P - Purchase I 14,0000 693.525 9.709 2.969.352
2021-11-04 2021-11-02 4 Medicxi Ventures Management (Jersey) Ltd AURA Common Stock C - Conversion I 2.275.827 2.275.827
2021-11-04 2021-11-02 4 Matrix Capital Management Company, LP See footnotes AURA Series E Convertible Preferred Stock C - Conversion I -2.327.870 0
2021-11-04 2021-11-02 4 Matrix Capital Management Company, LP See footnotes AURA Common Stock P - Purchase I 14,0000 1.785.000 24.990 4.112.870
2021-11-04 2021-11-02 4 Matrix Capital Management Company, LP See footnotes AURA Common Stock, par value $0.00001 per share ("Common Stock") C - Conversion I 2.327.870 2.327.870
2021-11-02 2021-11-02 4 de los Pinos Elisabet By EdIP Revocable Trust AURA Series A-2 Preferred Stock C - Conversion I -1.510 0
2021-11-02 2021-11-02 4 de los Pinos Elisabet By EdIP Revocable Trust AURA Series A-1 Preferred Stock C - Conversion I -3.042 0
2021-11-02 2021-11-02 4 de los Pinos Elisabet By EdIP Revocable Trust AURA Common Stock C - Conversion I 4.552 131.412
2021-11-02 2021-11-02 4 Johnson David Michael By Velocity Capital Management LLC AURA Series E Convertible Preferred Stock C - Conversion I -139.672 0
2021-11-02 2021-11-02 4 Johnson David Michael By Velocity Capital Management AURA Common Stock C - Conversion I 139.672 139.672
2021-10-29 2021-10-28 4 Johnson David Michael AURA Stock Option (Right to Buy) A - Award D 14,00 24.000 24.000
2021-10-29 2021-10-28 4 Rich Cadmus AURA Stock Option (Right to Buy) A - Award D 14,00 112.500 112.500
2021-10-29 2021-10-28 4 Rich Cadmus AURA Common Stock A - Award D 26.250 26.250
2021-10-29 2021-10-28 4 de los Pinos Elisabet AURA Stock Option (Right to Buy) A - Award D 14,00 318.750 318.750
2021-10-29 2021-10-28 4 de los Pinos Elisabet AURA Common Stock A - Award D 74.357 74.357
2021-10-29 2021-10-28 4 Mattessich Antony C. AURA Stock Option (Right to Buy) A - Award D 14,00 16.000 16.000
2021-10-29 2021-10-28 4 De Rosch Mark AURA Stock Option (Right to Buy) A - Award D 14,00 75.000 75.000
2021-10-29 2021-10-28 4 De Rosch Mark AURA Common Stock A - Award D 17.500 17.500
2021-10-29 2021-10-28 4 Feder Julie B AURA Stock Option (Right to Buy) A - Award D 14,00 112.500 112.500
2021-10-29 2021-10-28 4 Feder Julie B AURA Common Stock A - Award D 26.250 26.250
2021-10-29 2021-10-28 4 PAREKH RAJESH B AURA Stock Option (Right to Buy) A - Award D 14,00 16.000 16.000
2021-10-29 2021-10-28 4 Primiano Christopher Brett AURA Stock Option (Right to Buy) A - Award D 14,00 37.500 37.500
2021-10-29 2021-10-28 4 Primiano Christopher Brett AURA Common Stock A - Award D 8.750 8.750
2021-10-29 2021-10-28 4 Srivastava Sapna AURA Stock Option (Right to Buy) A - Award D 14,00 16.000 16.000
2021-10-28 3 de los Pinos Elisabet By: EdIP Revocable Trust AURA Common Stock I 126.860
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista